Profil
Boris Fain is the founder of two companies.
He founded Diagnose Early, Inc. and InterX, Inc. At Diagnose Early, Inc., he held no specific title.
At InterX, Inc., he held the titles of Chief Science Officer and Chief Technology Officer, but is no longer active in those roles.
Postes actifs de Boris Fain
Sociétés | Poste | Début |
---|---|---|
InterX, Inc.
InterX, Inc. Pharmaceuticals: MajorHealth Technology Part of NeoTX Therapeutics Ltd., InterX, Inc. develops cancer therapies. The company is based in Walnut Creek, CA. The company was founded by Roger David Kornberg, Boris Fain. The CEO is Paul Marinelli. InterX was acquired by NeoTX Therapeutics Ltd. on May 12, 2022. | Fondateur | - |
Anciens postes connus de Boris Fain
Sociétés | Poste | Fin |
---|---|---|
Diagnose Early, Inc.
Diagnose Early, Inc. Pharmaceuticals: MajorHealth Technology Diagnose Early, Inc. is a company that specializes in non-invasive breath and biometric testing. The company is based in Newark, CA. The company has developed a proprietary breath analysis technology and an AI health data platform that allows users to collect their health data in one place. The company's breath testing technology is designed to provide non-invasive detection of toxins and other chemicals that may pose a health threat in minutes. Diagnose Early was founded by Boris Fain, Chris Wheeler, and John Cunniff. Chris Wheeler has been the CEO since incorporation. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
InterX, Inc.
InterX, Inc. Pharmaceuticals: MajorHealth Technology Part of NeoTX Therapeutics Ltd., InterX, Inc. develops cancer therapies. The company is based in Walnut Creek, CA. The company was founded by Roger David Kornberg, Boris Fain. The CEO is Paul Marinelli. InterX was acquired by NeoTX Therapeutics Ltd. on May 12, 2022. | Health Technology |
Diagnose Early, Inc.
Diagnose Early, Inc. Pharmaceuticals: MajorHealth Technology Diagnose Early, Inc. is a company that specializes in non-invasive breath and biometric testing. The company is based in Newark, CA. The company has developed a proprietary breath analysis technology and an AI health data platform that allows users to collect their health data in one place. The company's breath testing technology is designed to provide non-invasive detection of toxins and other chemicals that may pose a health threat in minutes. Diagnose Early was founded by Boris Fain, Chris Wheeler, and John Cunniff. Chris Wheeler has been the CEO since incorporation. | Health Technology |